ContextVision’s Deep Learning experts will hold an oral presentation at the Medical Imaging & Deep Learning conference in London July 8–10
This paper presents an interesting and novel idea of a deep learning (DL) framework to segment potentially cancerous areas in prostate biopsies using semi-automatically generated data. The application of this paper is quite innovative and the proposed method seems to be a direct assistance to the clinical routine.
ContextVision Earns Acclaim from Frost & Sullivan for Its AI-powered INIFY™ Prostate Cancer Screening Platform
Based on its recent analysis of the European prostate cancer screening market, Frost & Sullivan recognises the Stockholm-based ContextVision AB with the 2019 European Technology Leadership Award for its INIFY™ Prostate platform.
ContextVision will have exclusive rights to the scanning cohort and access to anonymized associated clinical data - with cleared and structured histopathological descriptions, diagnosis and outcome data - for the defined patient cohorts and all commercial rights from output based on the data.The agreement gives ContextVision an opportunity to create AI-based decision support tools that will help doctors make more accurate treatment decisions. Today, many cancer patients suffer from life impairing side effects from treatments they did not need while other patients do not get treatment which is necessary.
Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 22, London Heathrow Marriott Hotel.
September 6, 2018, – ContextVision is making their second appearance in the field of digital pathology at ECP 2018, the 30th European Congress of Pathology, September 8–12 in Bilbao, Spain. Here, they will be introducing and demonstrating their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.
ContextVision recently made their first appearance in the field of digital pathology at ECDP/NDP 2018 – the 14th European Congress on Digital Pathology and the 5th Nordic Symposium on Digital Pathology, held in Helsinki, Finland, end of May.
ContextVision will attend the 30th European Congress of Pathology (ECP 2018) in Bilbao, Spain. Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 43, hall I + II on level -2 in the Euskalduna Conference Centre
June 20, 2018 – The installation was made through the fully integration with the Hospital's Laboratory Information System at the pathology department at Ospedale Cannizzaro in Catania, Italy.
May 28, 2018, – ContextVision will be introducing their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.